Downtrend on the daily chart: below its 50- and 200-day averages · 50-day below the 200-day · SuperTrend down since Jul 28 · below the Ichimoku cloud · RSI 26 (oversold) · MACD below its signal · 6% above its 52-week low
None of the 29 investors followed here reported a position in MDBH in their latest filing.
From each investor's quarterly 13F filing with the SEC: positions at the quarter's end, reported up to 45 days later. All investors
No member of Congress has disclosed a MDBH trade since 2025.
From House and Senate STOCK Act reports. Members disclose trades, not holdings, as value ranges up to 45 days later, so amounts are estimates and “last move” is a hint at who still holds it, not a position. All recent congress trades
| Date | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Apr 19, 2026 | Torpey Daniel ThomasDirector | — | 10K | — |
| Feb 8, 2026 | James Jeremy WilliamChief Financial Officer | Stock Award(Grant) at price 3.20 per share. | 10K | $32.00K |
| Feb 8, 2026 | Magennis Sean JamesDirector | Stock Award(Grant) at price 3.20 per share. | 10K | $32.00K |
| Feb 8, 2026 | Torpey Daniel ThomasDirector | Stock Award(Grant) at price 3.20 per share. | 10K | $32.00K |
| Feb 8, 2026 | James Jeremy WilliamChief Financial Officer | — | 10K | — |
| Feb 8, 2026 | Magennis Sean JamesDirector | — | 10K | — |
| Jan 22, 2026 | James Jeremy WilliamChief Financial Officer | Sale at price 3.34 - 6.24 per share. | 3.5K | $21.67K |
| Jan 1, 2026 | Marlett Christopher AOfficer, Director and Beneficial Owner | Purchase at price 3.50 per share. | 1.2K | $4.25K |
| Dec 30, 2025 | Marlett Christopher AOfficer, Director and Beneficial Owner | Purchase at price 3.18 - 3.35 per share. | 8.8K | $28.69K |
| Dec 8, 2025 | Brandon George HughPresident | Purchase at price 3.38 per share. | 3.7K | $12.51K |
| Dec 7, 2025 | Brandon George HughPresident | Purchase at price 3.29 - 3.52 per share. | 3.4K | $11.63K |
| Dec 2, 2025 | Brandon George HughPresident | Purchase at price 3.49 - 3.63 per share. | 8.1K | $29.00K |
| Oct 5, 2025 | Marlett Christopher AOfficer, Director and Beneficial Owner | Purchase at price 3.35 - 3.41 per share. | 4K | $13.50K |
| Aug 28, 2025 | Marlett Christopher AOfficer, Director and Beneficial Owner | Purchase at price 3.52 - 3.56 per share. | 3.2K | $11.40K |
| Aug 26, 2025 | Marlett Christopher AOfficer, Director and Beneficial Owner | Purchase at price 3.31 - 3.40 per share. | 3.9K | $13.19K |
| Aug 21, 2025 | Marlett Christopher AOfficer, Director and Beneficial Owner | Purchase at price 3.33 - 3.45 per share. | 2.4K | $8.14K |
| Aug 13, 2025 | Meline Susanne LDirector | Conversion of Exercise of derivative security at price 3.40 per share. | 10K | $34.00K |
| Aug 13, 2025 | James Jeremy WilliamDirector | Conversion of Exercise of derivative security at price 3.40 per share. | 10K | $34.00K |
| Aug 13, 2025 | Magennis Sean JamesDirector | Conversion of Exercise of derivative security at price 3.40 per share. | 10K | $34.00K |
| Aug 13, 2025 | Torpey Daniel ThomasDirector | — | 20K | — |
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Year |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -1.7 | -1.8 | -4.9 | 19.5 | -1.7 | 0.0 | -12.6 | -3.9 | -11.2 | -24.5 | −39.3% | ||
| 2025 | -2.2 | 9.4 | -8.6 | -27.2 | -15.3 | 17.9 | -8.3 | -15.3 | -3.3 | 13.3 | -7.7 | -7.7 | −48.5% |
| 2024 | -2.3 | 6.9 | -14.9 | -11.9 | -4.8 | -13.0 | 30.5 | -17.1 | -6.4 | -13.8 | 11.0 | -13.1 | −45.4% |
| 2023 | -9.0 | -1.7 | 12.5 | +0.6% |
No analyst coverage for this instrument.
MDB Capital Holdings, LLC, through its subsidiaries, primarily operates as a broker-dealer. The company operates in two segments, Broker Dealer & Intellectual Property Service, and Technology Development. The Broker Dealer & Intellectual Property Service segment operates as a full-service broker dealer firm, which focuses on conducting private and public security offerings, as well as providing research services for investment banking due diligence. The Technology Development segment develops a small molecule senescence platform. It provides services through MDB Capital and PatentVest platforms. The company was founded in 1997 and is based in Addison, Texas.